Autori: Dixon Mark
| Naslov | Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial (Article) |
| Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S  Mercadal Santiago Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude Genevray Magali Zharkov Artem Dixon Mark Brewster Michael Barrett Martin MacDonald David
|
| Info | LANCET HAEMATOLOGY, (2017), vol. 4 br. 6, str. E272-E282 |
| Projekat | F Hoffmann-La Roche |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study (Meeting Abstract) |
| Autori | Davies Andrew J Mihaljevic Biljana S Mercadal Santiago Mihaylov Georgi Leppa Sirpa Cotting Denise Veenstra Klaas Zharkov Artem Dixon Mark Barrett Martin Macdonald David
|
| Info | BLOOD, (2016), vol. 128 br. 22, str. - |
| Projekat | Takeda Pharmaceutical Company Ltd; |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
